ENKEPHALINERGIC AND DYNORPHINERGIC NEURONS IN THE SPINAL-CORD AND DORSAL-ROOT GANGLIA OF THE POLYARTHRITIC RAT - IN-VIVO RELEASE AND CDNA HYBRIDIZATION STUDIES
M. Pohl et al., ENKEPHALINERGIC AND DYNORPHINERGIC NEURONS IN THE SPINAL-CORD AND DORSAL-ROOT GANGLIA OF THE POLYARTHRITIC RAT - IN-VIVO RELEASE AND CDNA HYBRIDIZATION STUDIES, Brain research, 749(1), 1997, pp. 18-28
Complex and contradictory data have been reported regarding the change
s in spinal opioidergic systems associated with chronic inflammatory p
ain in the rat. In an attempt to solve these discrepancies, the in viv
o release of met-enkephalin and dynorphin and the expression of the co
rresponding propeptide genes were investigated at the spinal level in
arthritic rats and paired controls. A dramatic increase in the concent
ration of prodynorphin mRNA (+300-550%) and a less pronounced elevatio
n of that of dynorphin-like material (+40-50%) were found in the dorsa
l part of cervical and lumbar segments of the spinal cord in rats rend
ered arthritic by an intradermal injection of Freund's adjuvant four w
eeks prior to these measurements. In addition, the spinal release of d
ynorphin-like material (assessed through an intrathecal perfusion proc
edure in halothane-anaesthetized animals) was approximately twice as h
igh in arthritic rats as in controls. In spite of significant elevatio
ns in the levels of both met-enkephalin (+30-70%) and proenkephalin A
mRNA (+40-50%) in the dorsal part of cervical and lumbar segments, the
spinal release of metenkephalin-like material was decreased (-50%) in
arthritic rats as compared to paired controls. Proenkephalin A mRNA (
but not prodynorphin mRNA) could be measured in dorsal root ganglia, a
nd its levels were dramatically reduced in ganglia at the lumbar segme
nts in arthritic rats. Such parallel reductions in the spinal release
of met-enkephalin-like material and the levels of proenkephalin A mRNA
in dorsal root ganglia of arthritic rats support the idea that the ac
tivity of primary afferent enkephalinergic fibres decreases markedly d
uring chronic inflammatory pain.